| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T73 |
0-8 |
Sentence |
denotes |
Table 1. |
| T74 |
10-67 |
Sentence |
denotes |
SARS-CoV-2 Neutralizing Antibodies in Tested Plasma Pools |
| T75 |
68-80 |
Sentence |
denotes |
Week in 2020 |
| T76 |
81-118 |
Sentence |
denotes |
Parameter 13 14 15 16 20 24 28 |
| T77 |
119-174 |
Sentence |
denotes |
Plasma pools ≥LOD, % 0.0 1.3 1.3 6.3 0.0 5.0 7.0 |
| T78 |
175-218 |
Sentence |
denotes |
µNT50 of plasma pool titers ≥LOD, 1:X n.a. |
| T79 |
220-250 |
Sentence |
denotes |
37 5 6, 18, 26, 34, 87 n.a. |
| T80 |
252-289 |
Sentence |
denotes |
7, 10, 20, 22 4, 7, 8, 9, 12, 18, 24 |
| T81 |
290-349 |
Sentence |
denotes |
Number of plasma pools tested 40 80 80 80 100 80 100 |
| T82 |
350-443 |
Sentence |
denotes |
SARS-CoV-2 nAb positive plasma donors in Austria, % 0.00 0.21 0.21 1.04 0.00 0.83 1.17 |
| T83 |
444-530 |
Sentence |
denotes |
Cumulative COVID-19 incidence in Austria, %a 0.10 0.14 0.16 0.17 0.18 0.19 0.21 |
| T84 |
531-799 |
Sentence |
denotes |
Abbreviations: µNT50, neutralization titer for 50% of the wells; COVID-19, coronavirus disease 2019; LOD, limit of detection; n.a., not applicable; nAb, neutralizing antibody; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. |
| T85 |
800-929 |
Sentence |
denotes |
aSARS-CoV-2 PCR-positive individuals per 100 000 population in Austria are described as cumulative COVID-19 incidence in percent. |
